Randomized Phase III Study Comparison Between Conventional Chemotherapy and High-Dose Therapy Followed by Autologous Purged Stem-Cell Transplantation in Patients With Follicular Lymphoma Stage III,IV First-Line Treatment for Patients Younger Than 60 Years Old With a High Tumor Burden
Age 8-60 years old follicular lymphoma Not previously treated Stage II bulky, III or IV An
Arbor classification high tumor burden
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
event free survival
from diagnosis to first event
Yes
Philippe COLOMBAT, MD PHD
Principal Investigator
Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang GOELAMS
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
GOELAMS 064
NCT00696735
June 1994
May 2006
Name | Location |
---|